HOB Biotech Group Corp.,Ltd (SHA:688656)
164.39
+0.04 (0.02%)
Nov 3, 2025, 2:44 PM CST
SHA:688656 Revenue
HOB Biotech Group Corp.,Ltd had revenue of 102.52M CNY in the quarter ending September 30, 2025, a decrease of -1.64%. This brings the company's revenue in the last twelve months to 387.48M, down -3.44% year-over-year. In the year 2024, HOB Biotech Group Corp.,Ltd had annual revenue of 402.34M with 2.01% growth.
Revenue (ttm)
387.48M
Revenue Growth
-3.44%
P/S Ratio
26.77
Revenue / Employee
739.47K
Employees
529
Market Cap
10.37B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 402.34M | 7.93M | 2.01% |
| Dec 31, 2023 | 394.41M | 74.01M | 23.10% |
| Dec 31, 2022 | 320.39M | 2.68M | 0.84% |
| Dec 31, 2021 | 317.71M | 95.85M | 43.20% |
| Dec 31, 2020 | 221.86M | -37.27M | -14.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Huadong Medicine | 43.09B |
| WuXi AppTec | 43.07B |
| Yunnan Baiyao Group Co.,Ltd | 40.77B |
| Shanghai Fosun Pharmaceutical (Group) | 39.55B |
| Shenzhen Mindray Bio-Medical Electronics | 33.07B |
| Jiangsu Hengrui Medicine | 30.98B |
| Zhejiang NHU Company | 22.47B |
| Aier Eye Hospital Group | 22.17B |